Latanoprost versus timolol as first choice therapy in patients with ocular hypertension A cost-effectiveness analysis

Andrea Peeters, Jan S. A. G. Schouten*, Johan L. Severens, Fred Hendrikse, Martin H. Prins, Carroll A. B. Webers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)146-154
JournalActa Ophthalmologica
Issue number2
Publication statusPublished - Mar 2012


  • blindness
  • cost-effectiveness
  • glaucoma
  • latanoprost
  • modelling
  • ocular hypertension
  • timolol

Cite this